DE602004018623D1 - Halogenierte triptolid-derivate als immunmodulatoren und antikrebsmittel - Google Patents
Halogenierte triptolid-derivate als immunmodulatoren und antikrebsmittelInfo
- Publication number
- DE602004018623D1 DE602004018623D1 DE602004018623T DE602004018623T DE602004018623D1 DE 602004018623 D1 DE602004018623 D1 DE 602004018623D1 DE 602004018623 T DE602004018623 T DE 602004018623T DE 602004018623 T DE602004018623 T DE 602004018623T DE 602004018623 D1 DE602004018623 D1 DE 602004018623D1
- Authority
- DE
- Germany
- Prior art keywords
- sup
- sub
- anticrements
- immunomodulators
- halogenated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- DFBIRQPKNDILPW-CIVMWXNOSA-N Triptolide Chemical class O=C1OCC([C@@H]2C3)=C1CC[C@]2(C)[C@]12O[C@H]1[C@@H]1O[C@]1(C(C)C)[C@@H](O)[C@]21[C@H]3O1 DFBIRQPKNDILPW-CIVMWXNOSA-N 0.000 title 1
- 239000002955 immunomodulating agent Substances 0.000 title 1
- 229940121354 immunomodulator Drugs 0.000 title 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 abstract 2
- 229910052731 fluorine Inorganic materials 0.000 abstract 2
- 239000011737 fluorine Substances 0.000 abstract 2
- 206010062016 Immunosuppression Diseases 0.000 abstract 1
- 230000006907 apoptotic process Effects 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 230000030833 cell death Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000001506 immunosuppresive effect Effects 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/22—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Rheumatology (AREA)
- Transplantation (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Obesity (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US44997603P | 2003-02-25 | 2003-02-25 | |
US10/786,663 US6943259B2 (en) | 2003-02-25 | 2004-02-24 | Halogenated triptolide derivatives as immunomodulators and anticancer agents |
PCT/US2004/005612 WO2004075853A2 (en) | 2003-02-25 | 2004-02-25 | Halogenated triptolide derivatives as immunomodulators and anticancer agents |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602004018623D1 true DE602004018623D1 (de) | 2009-02-05 |
Family
ID=32930535
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602004018623T Expired - Lifetime DE602004018623D1 (de) | 2003-02-25 | 2004-02-25 | Halogenierte triptolid-derivate als immunmodulatoren und antikrebsmittel |
Country Status (8)
Country | Link |
---|---|
US (2) | US6943259B2 (de) |
EP (1) | EP1603555B1 (de) |
JP (1) | JP4647587B2 (de) |
AT (1) | ATE418557T1 (de) |
AU (1) | AU2004216115A1 (de) |
CA (1) | CA2515842A1 (de) |
DE (1) | DE602004018623D1 (de) |
WO (1) | WO2004075853A2 (de) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7847109B2 (en) * | 2002-05-31 | 2010-12-07 | Pharmagenesis, Inc. | Triptolide derivatives for modulation of apoptosis and immunosuppression |
US6943259B2 (en) | 2003-02-25 | 2005-09-13 | Pharmagenesis, Inc. | Halogenated triptolide derivatives as immunomodulators and anticancer agents |
WO2005062913A2 (en) * | 2003-12-24 | 2005-07-14 | Pharmagenesis, Inc. | Triplide 5,6-derivatives as immunomodulators and anticancer agents |
CN1917893A (zh) * | 2004-02-09 | 2007-02-21 | 美国泛华医药公司 | 从雷公藤多苷中分离雷公藤内酯醇化合物的方法 |
ATE554758T1 (de) * | 2004-03-02 | 2012-05-15 | Pharmagenesis Inc | Triptolid-lacton-ring-derivate als immunmodulatoren und mittel gegen krebs |
CN1980649A (zh) * | 2004-05-17 | 2007-06-13 | 康宾纳特克斯公司 | 治疗免疫炎性疾病的方法和试药 |
US20070244080A1 (en) * | 2004-06-25 | 2007-10-18 | Pharmagenesis, Inc. | Method for Treatment of Inflammatory Disorders Using Triptolide Compounds |
WO2006044496A2 (en) | 2004-10-13 | 2006-04-27 | Pharmagenesis, Inc. | Identification and screening of triptolide target molecules |
US7821973B2 (en) * | 2006-10-24 | 2010-10-26 | Hewlett-Packard Development Company, L.P. | Sharing of host bus adapter context |
WO2009023201A1 (en) * | 2007-08-16 | 2009-02-19 | Myelorx Llc | Rigid derivatives of triptolide as anticancer, immune suppressant, anti-fibrosis, and cns protectant agents |
US8268882B2 (en) | 2009-02-05 | 2012-09-18 | Pharmagenesis, Inc. | Triptolide C-ring derivatives as anticancer agents and immune modulators |
JP6000122B2 (ja) | 2009-05-07 | 2016-09-28 | リージェンツ オブ ザ ユニバーシティ オブ ミネソタ | トリプトリド製品 |
US9150600B2 (en) | 2009-05-07 | 2015-10-06 | Regents Of The University Of Minnesota | Triptolide prodrugs |
CN113480590B (zh) * | 2021-08-12 | 2023-02-17 | 云南西力生物技术股份有限公司 | 雷公藤大戟酮(wilfordeuphone)及其制备方法和在药物上的应用 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1027371C (zh) * | 1989-09-08 | 1995-01-11 | 中国医学科学院皮肤病研究所 | 二萜内酯化合物的合成方法 |
US5430054A (en) * | 1989-12-22 | 1995-07-04 | Jiangsu Family Planning Institute | Preparation methods of diterpene lactone compounds and application of the same to antifertility |
CN1052859A (zh) * | 1989-12-22 | 1991-07-10 | 中国医学科学院皮肤病研究所 | 17-羟基雷藤内酯醇及类似物的结构与制备方法 |
US5663335A (en) * | 1996-03-01 | 1997-09-02 | Pharmagenesis, Inc. | Immunosuppressive compounds and methods |
US5962516A (en) * | 1997-02-28 | 1999-10-05 | Pharmagenesis, Inc. | Immunosuppressive compounds and methods |
ES2178207T3 (es) * | 1997-05-23 | 2002-12-16 | Aventis Pharma Inc | Nuevos derivados de triptolida utiles en el tratamiento de enfermedades autoinmunes. |
AU764123B2 (en) * | 1998-09-02 | 2003-08-07 | Pharmagenesis, Inc. | Triptolide prodrugs having high aqueous solubility |
US6620843B2 (en) * | 2001-01-19 | 2003-09-16 | Pharmagenesis | Anticancer treatment using triptolide prodrugs |
US6943259B2 (en) | 2003-02-25 | 2005-09-13 | Pharmagenesis, Inc. | Halogenated triptolide derivatives as immunomodulators and anticancer agents |
WO2005000291A1 (en) * | 2003-06-27 | 2005-01-06 | Pharmagenesis, Inc. | Method for treatment of idiopathic pulmonary fibrosis using triptolide derivatives |
-
2004
- 2004-02-24 US US10/786,663 patent/US6943259B2/en not_active Expired - Fee Related
- 2004-02-25 EP EP04714219A patent/EP1603555B1/de not_active Expired - Lifetime
- 2004-02-25 WO PCT/US2004/005612 patent/WO2004075853A2/en active Application Filing
- 2004-02-25 JP JP2006503870A patent/JP4647587B2/ja not_active Expired - Fee Related
- 2004-02-25 CA CA002515842A patent/CA2515842A1/en not_active Abandoned
- 2004-02-25 DE DE602004018623T patent/DE602004018623D1/de not_active Expired - Lifetime
- 2004-02-25 AU AU2004216115A patent/AU2004216115A1/en not_active Abandoned
- 2004-02-25 AT AT04714219T patent/ATE418557T1/de not_active IP Right Cessation
-
2005
- 2005-08-23 US US11/210,677 patent/US7417069B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US20050288364A1 (en) | 2005-12-29 |
EP1603555B1 (de) | 2008-12-24 |
EP1603555A2 (de) | 2005-12-14 |
EP1603555A4 (de) | 2006-11-02 |
JP2007524581A (ja) | 2007-08-30 |
WO2004075853A3 (en) | 2004-12-29 |
ATE418557T1 (de) | 2009-01-15 |
JP4647587B2 (ja) | 2011-03-09 |
WO2004075853A2 (en) | 2004-09-10 |
WO2004075853A9 (en) | 2004-11-11 |
US20040198808A1 (en) | 2004-10-07 |
US6943259B2 (en) | 2005-09-13 |
US7417069B2 (en) | 2008-08-26 |
AU2004216115A1 (en) | 2004-09-10 |
CA2515842A1 (en) | 2004-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE602004018623D1 (de) | Halogenierte triptolid-derivate als immunmodulatoren und antikrebsmittel | |
DK0907652T3 (da) | Immunosuppressive forbindelser og fremgangsmåder | |
CO4700455A1 (es) | Derivados tetraciclicos y proceso para su preparacion | |
BRPI0412251A (pt) | tratamento de contaminantes ambientais | |
DE69932649D1 (de) | Triptolid-Prodrugs mit hoher Wasserlöslichkeit | |
ES2193252T3 (es) | Quinolonas y su uso terapeutico. | |
ES2078659T3 (es) | Procedimiento y composicion que utilizan dioxido de carbono densificado y un aditivo limpiador para limpiar tejidos. | |
NO20045527L (no) | Kombinasjon av en IBAT-inhibitor og et metallsalt for behandling av diare | |
ES2192031T3 (es) | Nuevas amidas aromaticas, su procedimiento de preparacion y su aplicacion como medicamentos. | |
AU6894800A (en) | Caspase inhibitors and uses thereof | |
ATE439355T1 (de) | 2 aminocarbonyl-substituierte piperazin- oder diaza-cyclische verbindungen als apoptose-protein-inhibitor (iap)-modulatoren | |
ATE288894T1 (de) | Aromatische maleimide und ihre verwendung als photoinitiatoren | |
ATE209187T1 (de) | Fluorinierte 2-nitroimidazole analoge zur detektion von hypoxischen tumorzellen | |
EA200300450A1 (ru) | Фармацевтические растворы соединений модафинила | |
ES8403472A1 (es) | Procedimiento para la obtencion de un medio para combatir las pestes a base de como minimo de aminocetal. | |
ES2180893T3 (es) | Benzotiofenos, composiciones que los contienen y procedimientos. | |
ATE441626T1 (de) | Azeotropähnliche zusammensetzungen und deren verwendung | |
DE69815544D1 (de) | Herstellung und verwendung von ortho-sulfonamido bicyclische heteroaryl hydroxamsäure derivate als matrix-metalloproteinase und tace inhibitoren | |
DK0559612T3 (da) | Dioxolanderivater som pesticider | |
KR940021493A (ko) | 클로로메틸알킬에테르의 제조방법 | |
FI824155A0 (fi) | Foerfarande foer framstaellning av 3,7a-diazacyklohepta/j,k/fluoren | |
IT1271973B (it) | Derivati del benzofurano e loro uso come stabilizzanti verso le radiazioni uv. | |
JPS52144603A (en) | Stabilization of chlorinated hydrocarbons | |
ATE238781T1 (de) | Verwendung von katecholderivaten als proteinaseinhibitoren | |
SE7710841L (sv) | Anhydro socker |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |